TMDX
TMDX
US89377M1099
TransMedics Group, Inc.
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 75/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.9x as much as the broader market.

Beta (Market Relation)
1.93x
Above average
Volatility (5Y p.a.)
71.4% p.a.
5-Year Horizon
Max Drawdown (5Y)
-67.8%
5-Year Horizon
Sharpe Ratio
0.30
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Stable Long-Term Volatility High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -33.1%
3 Years 68.9% -67.8% 0.23 +18%
5 Years 71.4% -67.8% 0.3 +23.6%
10 Years — — — —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 1.93 indicates above-average volatility compared to the broader market.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (71.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -67.8% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
5 ISS Score: 5 / 10
Audit Risk
10 ISS Score: 10 / 10
Board Risk
3 ISS Score: 3 / 10
Short Ratio
11.43
ende